Ellepra-M Tablet
Marketer
Lincoln Pharmaceuticals Ltd
Salt Composition
Montelukast (10mg) + Fexofenadine (120mg)
Overview Ellepra-M Tablet
Aller-Ease Combo tablets combine medications to alleviate allergy symptoms like nasal congestion, runny nose, sneezing, watery eyes, and sinus pressure. Dosage and duration are determined by your physician and depend on your response to treatment. Continue using the medication as directed; premature discontinuation may lead to symptom recurrence or worsening. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include nausea, diarrhea, vomiting, rash, flu-like symptoms, and headache; most are transient. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or mentally demanding tasks until the effects are known. Alcohol should be avoided due to increased drowsiness. Never self-medicate or share your prescription. Adequate hydration is recommended. Inform your physician of liver or kidney conditions, pregnancy, pregnancy plans, or breastfeeding before starting this medication.
Uses of Ellepra-M Tablet
Allergic rhinitis management: addressing sneezing and nasal discharge.
Major Benefits of Ellepra-M Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid crushing, chewing, or breaking it. Ellepra-M Tablets can be ingested with or without food, but consistent timing is recommended.
Common Side effects of Ellepra-M Tablet:
- Nausea
- Diarrhea
- Vomiting
- Flu-like symptoms
- Headache
- Drowsiness
- Dizziness
- Upper respiratory tract infection
- Increased transaminase level in blood
- Fever
- Skin rash
How to use Ellepra-M Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ellepra-M Tablets can be consumed with or without food, though consistent timing is recommended.
How Ellepra-M Tablet works:
Montelukast, a leukotriene receptor inhibitor, counteracts the effects of leukotrienes, inflammatory chemical messengers. This action diminishes airway and nasal inflammation, alleviating associated symptoms. Fexofenadine, an antihistamine, similarly inhibits histamine, another chemical messenger, thereby reducing allergic responses such as rhinorrhea, lacrimation, and sneezing.
SAFETY ADVICE
AlcoholCAUTION
Alcohol consumption while taking Ellepra-M Tablets requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Ellepra-M tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Based on available evidence, Ellepra-M Tablet appears to pose minimal risk to breastfeeding infants. Studies in humans show little indication of significant harm to the child.
DrivingUNSAFE
Taking Ellepra-M Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney disease should use Ellepra-M Tablets cautiously, potentially requiring dosage modification. Consult your physician. Severe drowsiness can occur in those with end-stage renal failure.
LiverSAFE IF PRESCRIBED
The use of Ellepra-M Tablets in individuals with liver conditions appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Ellepra-M Tablet :
Should you forget a dose of Ellepra-M Tablet, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ellepra-M Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |

